A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

Starting soon · Phase 3

Conditions studied: Hypertension

In brief

A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential Hypertension

Key facts

Study ID

NCT07660796

Run by

Hanmi Pharmaceutical Company Limited

People needed

256

Starts

2026-07-06

Expected to finish

2027-11-30

Last updated by the study team

2026-06-30

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with essential hypertension whose blood pressure measured in visit1 corresponds to the following conditions
• mean sitSBP < 180 mmHg and mean sitDBP < 110 mmHg for patients receiving any BP-lowering drug within 1 month prior to Visit 1
• 140 mmHg ≤ mean sitSBP < 180 mmHg and 60 mmHg ≤ mean sitDBP < 110 mmHg for patients not receiving BP-lowering drugs within 1 month prior to Visit 1
• Patients with essential hypertension who meet 140 mmHg ≤ mean sitSBP < 180 mmHg and 60 mmHg ≤ mean sitDBP < 110 mmHg at Visit 2

You may not qualify if…

• Difference between arms greater than 20 mmHg for mean sitSBP or 10 mmHg for mean sitDBP at Visit 1
• Patients who have taken more than three components of Blood pressure medication within 3 months prior to Visit 1
• Orthostatic hypotension with symptoms within 3 months prior to visit 1
• Secondary hypertensive patient or suspected to be
• Clinically significant hematological finding
• Severe heart disease or severe neurovascular disease
• Moderate or malignant retinopathy
• Uncontrolled diabetes mellitus or type I diabetes mellitus
• Active gout or hyperuricemia
• Severe renal diseases
• Severe or active hepatopathy
• Hypokalemia or Hyperkalemia
• Hyponatremia or Hypernatremia
• Hypercalcemia
• History of malignancy tumor
• History of autoimmune disease
• History of alcohol or drug abuse
• Positive to pregnancy test, nursing mother, intention on pregnancy
• Considered by investigator as not appropriate to participate in the clinical study with other reason

Where it is running

• Donggguk University Ilsan Hospital — Goyang-si, Gyeonggi-do, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.